🇩🇪 Germany Country × Condition
melanoma Clinical Trials in Germany
Active clinical trials for melanoma with research sites in Germany. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 3 // Recruiting: 3 Phases: Phase 2 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇩🇪 Germany
Active Trials in Germany (3)
NCT05229614 Phase 2
Recruiting
Immunotherapy and Carbon Ion Radiotherapy In Solid Cancers With Stable Disease
Enrollment
27 pts
Country
🇩🇪 Germany
CNAO National Center of Oncological...
View Trial → NCT05280314 Phase 2
Recruiting
Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors
Enrollment
60 pts
Country
🇩🇪 Germany
IO Biotech
View Trial → NCT06680323
Recruiting
Identification of Risk Factors, Exposomics and Genetic Susceptibility of Melanoma in Children, Adolescents and Young Adults
Enrollment
200 pts
Country
🇩🇪 Germany
University Hospital Tuebingen
View Trial → Frequently Asked Questions
How many melanoma clinical trials are active in Germany?
There are currently 3 active clinical trials for melanoma with sites in Germany, of which 3 are actively recruiting patients.
How can I join a melanoma clinical trial in Germany?
To join a melanoma clinical trial in Germany, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Germany directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are melanoma trials in Germany?
Active melanoma trials in Germany span Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology